Archives
230 / 652
Stocks
Ravi Mehta's Steadview Capital sells 21 lakhs shares worth 343 crore in Shriram City Union Finance
Shriram City Union Finance Limited (Shriram City) is part of the three decade-old Shriram Group. As a deposit-accepting non-banking financial company ...
Premium
Portfolio Review: Monsoon Portfolio Returns 9.59% in One Month
The Capital Mind Monsoon Portfolio At the start of the monsoons we have created the CM-Monsoon portfolio. The portfolio consists of the stocks which have ...
Premium
StratOptions: Brexit Helps Us Close The Month With 2.5%, June Edition Part 2
This time we took the volatility on the Brexit day to get a trade that made us a decent profit. Even though the market rebounded nearly 300 points, we ...
General
On Slack: 27/km day, Machine Beats Man, RBI coffers and much more…
The Slack Discussions The Slack group at Capital Mind Premium has been extremely active and if you haven’t been there (Premium subscribers only), pop us a ...
Stocks
DLF Promoter Stake Increase: How To Differentiate Rumour From Reality
Economic Times carried an article yesterday which took DLF shares up nearly 8%, because, goodness the promoter was going to pump in 10,000 cr. into the company ...
Foundations
Video: How To Park Your Money, Save 80% Tax & Also Generate Cash Flow!
Capitalmind speaks of a new way to allocate a lumpsum cash amount and recover interest from it, every month and pay 80% less tax compared to a Fixed ...
Economy
Banks: MCLR Update – June 30, 2016
As a follow-up note on MCLR (Marginal Cost of funds based Lending Rate) and how it is changing the way banks lend in India, we are publishing the rates of ...
Stocks
Sugar Stocks – The Multi Bagger of The Year!
The consumer are facing the bitter price of sugar, but the investors are enjoying the flavor of the sweet commodity. When the market was grappling with ...
Stocks
Tano Capital cuts stake in Shilpa Medicare on the heels of amalgamation with Navya Biologicals
Shilpa Medicare deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides / Biotech ...
General
Will Britain’s exit from Europe impact the Pharmaceutical Industry?
Yes. Remember this that UK on its own, represents 2.5% of the world pharmaceutical market (the market is over $1 trillion) and the market has not grown to this ...
